Accumulation of "small dense" low density lipoproteins (LDL) in a homozygous patients with familial defective apolipoprotein B-100 results from heterogenous interaction of LDL subfractions with the LDL receptor.
- 1 December 1993
- journal article
- case report
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 92 (6) , 2922-2933
- https://doi.org/10.1172/jci116915
Abstract
The interaction of LDL and LDL subfractions from a patient homozygous for familial defective apoB-100 (FDB) has been studied. His LDL cholesterol ranged from 2.65 to 3.34 g/liter. In cultured fibroblasts, binding, internalization, and degradation of the patient's LDL was diminished, but not completely abolished. The patient's apolipoprotein E concentration was low, and the amount of apolipoprotein E associated with LDL was not elevated over normal. LDL were separated into six subfractions: LDL-1 (1.019-1.031 kg/liter), LDL-2 (1.031-1.034 kg/liter), LDL-3 (1.034-1.037 kg/liter), LDL-4 (1.037-1.040 kg/liter), LDL-5 (1.040-1.044 kg/liter), and LDL-6 (> 1.044 kg/liter). LDL-5 and LDL-6 selectively accumulated in the patient's plasma. Concentrations of LDL-1 to 3 were normal. The LDL receptor-mediated uptake of LDL-1 and LDL-2 could not be distinguished from normal LDL. LDL-3 and LDL-4 displayed reduced uptake; LDL-5 and LDL-6 were completely defective in binding. When apolipoprotein E-containing particles were removed by immunoabsorption before preparing subfractions, LDL-3 and LDL-4, but not LDL-1 and LDL-2, retained some receptor binding activity. We conclude that in FDB, LDL-1 and LDL-2 contain sufficient apolipoprotein E to warrant normal cellular uptake. In LDL-3 and LDL-4, the defective apoB-100 itself displays some receptor binding; LDL-5 and LDL-6 are inable to interact with LDL receptors and accumulate in plasma.Keywords
This publication has 48 references indexed in Scilit:
- Determination of Lipoprotein(a): Evaluation of Three Methodscclm, 1993
- Familial defective apolipoprotein B-100: mild hypercholesterolaemia without atherosclerosis in a homozygous patientThe Lancet, 1992
- Response to cholesterol-lowering drugs in familial defective apolipoprotein B-100Atherosclerosis, 1991
- Phenotyping of apolipoprotein E by immunoblotting in immobilized pH gradientsElectrophoresis, 1991
- Cellular metabolism of human plasma intermediate-density lipoprotein (IDL)Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990
- Structure of human low-density lipoprotein subfractions determined by X-ray small-angle scatteringBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1990
- Role of apolipoprotein E in lipoprotein metabolismAmerican Heart Journal, 1987
- The metabolism of very low density and intermediate density lipoproteins in patients with familial hypercholesterolaemiaAtherosclerosis, 1982
- Radioimmunoassay studies of human apolipoprotein E.Journal of Clinical Investigation, 1980
- Lipolysis Produces Changes in the Immunoreactivity and Cell Reactivity of Very Low Density LipoproteinsJournal of Clinical Investigation, 1979